Secondary acute promyelocytic leukemia following irinotecan and oxaliplatin for advanced colon cancer.
Merrouche
Y
Y
Mugneret
F
F
Cahn
J-Y
JY
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D000077146:Irinotecan; D015473:Leukemia, Promyelocytic, Acute / Q000139:chemically induced* / Q000473:pathology*; D009362:Neoplasm Metastasis; D009944:Organoplatinum Compounds / Q000009:adverse effects; D000077150:Oxaliplatin
D009944:Organoplatinum Compounds; D000077150:Oxaliplatin; D000077146:Irinotecan; D002166:Camptothecin